Company news
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) news
Harmony Biosciences Holdings, Inc. news releases on 6ix. Latest, May 11, 2021: Harmony Biosciences Reports First Quarter 2021 Results and Business Updates
Press releases — page 4
Harmony Biosciences Reports First Quarter 2021 Results and Business Updates
May 10, 2021
Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting
April 26, 2021
Harmony Biosciences Announces Date of First Quarter 2021 Financial Results
April 26, 2021
Harmony Biosciences To Present WAKIX® (Pitolisant) Data At The 2021 AAN Annual Meeting
April 11, 2021
Harmony Biosciences Launches Grant Program To Address Inequities In The Delivery Of Healthcare In Patients With Sleep Disorders
April 6, 2021
Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates
March 24, 2021
Harmony Biosciences Hosts Summit Which Sheds Light on Impact of Sleep Disruption in Rare Diseases
March 18, 2021
Harmony Biosciences Highlights Publication of WAKIX® (pitolisant) Efficacy Data in Sleep Medicine
March 16, 2021
Harmony Biosciences Appoints Sandip Kapadia as Chief Financial Officer
March 14, 2021
Harmony Biosciences Announces Date Of Fourth Quarter And Full Year 2020 Financial Results
March 3, 2021
Harmony Biosciences Certified As A Great Place To Work For The Third Year In A Row
March 1, 2021
Harmony Biosciences To Be Added To Russell 2000® And Russell 3000® Indexes
December 16, 2020
Harmony Biosciences Enrolls First Patient In Phase 2 Trial Evaluating Pitolisant For Excessive Daytime Sleepiness In Patients With Prader-Willi Syndrome
December 14, 2020
Harmony Biosciences Reports Third Quarter 2020 Financial Results and Business Updates
November 11, 2020
Harmony Biosciences Appoints Mark Graf And Eric Motley To Its Board Of Directors
November 10, 2020
Harmony Biosciences Announces Date Of Third Quarter 2020 Financial Results
October 27, 2020
Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX® (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy
October 13, 2020
Harmony Biosciences Announces Recipients Of 2020 Patients At The Heart Grant On Second Annual World Narcolepsy Day
September 21, 2020
Harmony Biosciences Presents Efficacy And Safety Analyses For WAKIX® (pitolisant) At Virtual SLEEP 2020
August 27, 2020
Harmony Biosciences To Present New Data For WAKIX® (pitolisant) At SLEEP 2020 Annual Meeting
August 23, 2020
Harmony Biosciences Announces Closing Of Its Upsized Initial Public Offering And Exercise In Full Of Underwriters' Option To Purchase Additional Shares
August 20, 2020
Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering
August 17, 2020